COMPARISON OF SARS-CoV ANTIBODY TITER LEVELS AGAINST ABO BLOOD TYPE, AGE, AND GENDER IN CONVALESCENT PLASMA DONATIONS
DOI:
https://doi.org/10.61942/msj.v2i1.82Keywords:
Antibody Titer, SARS-CoV, blood type, age, genderAbstract
An important requirement to become a convalescent plasma donor is a standardized SARS-CoV antibody titer. However, not all Covid-19 survivors pass the plasma donor selection due to low antibody titer. This research aims to determine the comparison of SARS-CoV antibody titer levels with blood type, age and gender of Covid-19 convalescent plasma donors at blood donation unit PMI Semarang City. This study is an analytical observational study with a cross sectional design, using 300 data on convalescent plasma donors. The sampling technique used was purposive sampling. Differences in SARS-CoV antibody titer levels based on blood type, age, and gender were tested using SPSS 25. Donors involved in this study were divided based on the conversion of convalescent plasma titer levels, namely 1:80 (37%), 1:160 (4%), 1:250 (10.3%) and 1:640 (48.7%). Based on blood type data, most convalescent plasma donors have blood type O (42%) with the highest titer levels in the 1:640 category (48.7%). The highest mean titer level was found in blood group B which was 382.09. The results of the Kruskal-Wallis test showed no significant difference in titer levels by blood group, p=0.622 (>0.05). In the parameter of donor age, SARS-CoV antibody titer levels also showed no significant difference in donor age, both adolescent, adult and elderly donors with a value of p=0.598 (p>0.05). In line with these results, the chi square test of differences in antibody titres based on gender also showed no significant difference, p value=0.127 (p>0.05). High and low antibody titres of convalescent plasma donors are not determined by blood type, age and gender of the donor.
Downloads
References
Abdul-Hamid NA, Wahongan GJP & Tuda JSB. 2021. Deteksi Antibodi Imunoglobulin M dan Imunoglobulin G Anti Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Jurnal Biomedik, 13(1), 44. https://doi.org/10.35790/jbm.13.1.2021.31753
Aini R, Syafrudin M. 2022. Titer Antibodi IgM dan IgG pada Donor Plasma Konvalesen IgM and IgG Antibody Titers on Convalenced Plasma Donors. Bhakti Setya Medika;7(1):50–6. https://doi.org/10.56727/bsm.v7i1.87
Bloch, EM et al. 2021. ABO Blood groups and SARS-CoV-2 antibody response in a convalescent donor population. Vox Sanguinis, 116(7), pp. 766-773. doi: 10.1111/vox.13070
Focosi D & Franchini M. 2021. Clinical predictors of SARS-CoV- 2 neutralizing antibody titers in COVID- ¬ 19 convalescents : Implications for convalescent plasma donor recruitment. Eur J Haematol. 107(1): 24–28. March, 24–28. https://doi.org/10.1111/ejh.13630
Hayes, C. et al., 2021. Blood group O convalescent plasma donation have significantly lower levels of SARS-CoV-2 IgG antibodies compared to blood groups A donations. Transfusion, 61(8), pp. 2245-2249
He R, Lin H, Xie S, Lv Q, Kong Y, Li L, et al. Donor tolerability of convalescent plasma donation. J Clin Apher. 2021;36(3):429–36.
Ishaq SE, Abdulqadir SZ, Khudhur ZO, Omar SA, Qadir MK, Awla HK, Rasul MF, Bapir AA, Zanichelli A, Mansoor MK, Kaleem M, Rizwan MA, Smail SW, Babaei E. Comparative study of SARS-CoV-2 antibody titers between male and female COVID-19 patients living in Kurdistan region of Iraq. Gene Rep. 2021 Dec;25:101409. doi: 10.1016/j.genrep.2021.101409. Epub 2021 Oct 24. PMID: 34722951; PMCID: PMC8541827.
Janiaud P, Axfors C, Schmitt AM, Gloy V, Ebrahimi F, Hepprich M, et al. Association of Convalescent Plasma Treatment with Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-analysis. JAMA - J Am Med Assoc. 2021;325(12):1185–95.
Kementerian Kesehatan Republik Indonesia. 2020. Pedoman Pencegahan dan Pengendalian COVID-19. Infeksiemerging.kemkes.go.id (diakses Februari 2022)
Klassen SA, Senefeld JW, Senese KA, Johnson PW, Wiggins CC, Baker SE, et al. Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence. Front Med. 2021;8(June):2–10.
Klein, S. L., Pekosz, A., Park, H. S., Ursin, R. L., Shapiro, J. R., Benner, S. E., Littlefield, K., Kumar, S., Naik, H. M., Betenbaugh, M. J., Shrestha, R., Wu, A. A., Hughes, R. M., Burgess, I., Caturegli, P., Laeyendecker, O., Quinn, T. C., Sullivan, D., Shoham, S., … Tobian, A. A. R. (2020). Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population. Journal of Clinical Investigation, 130(11), 6141–6150. https://doi.org/10.1172/JCI142004
Mehew, J., Johnson, R., Roberts, D., & Harvala, H. (2020). Convalescent plasma for COVID-19 : male gender, older age and hospitalisation associated with high neutralising antibody levels, England , 22 April to 12 May 2020. May
Fawzy.N.A, Awaluddin.N, Muntasir. 2024. Processing Of Squid (Loligo Sp.) Cartilage Waste As Antibacterial Handwash, Majority Science Journal (MSJ), Vol. 2 No. 1, February 2024
Rajendran K, Krishnasamy N, Rangarajan J, Rathinam J, Natarajan M, Ramachandran A. Convalescent plasma transfusion for the treatment of COVID-19: Systematic review. J Med Virol. 2020;92(9):1475–83.
Tiberghien P, de Lamballerie X, Morel P, Gallian P, Lacombe K, Yazdanpanah Y. Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how?. Vox Sang. 2020;115(6):488–94.
Wardhani, S. O., Fajar, J. K., Nurarifah, N., Hermanto, D. H., Fatonah, S., Djajalaksana, S., Fatoni, A. Z., Arsana, P. M., Wulandari, L., Soegiarto, G., Dhama, K., & Harapan, H. (2021). The predictors of high titer of anti SARS-CoV-2 antibody of convalescent plasma donors. Clinicall Epidemiology and Global Health, 11(April), 100763. https://doi.org/10.1016/j.cegh.2021.10076 3
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Resti Ariani, Rina Puspita, Anna Kartika Yuli Astuti, Aulia Dewi Lestari, Andriani Setiawan Dewi, Maria Kurniati Manggina Open
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
